Gastroenterology

NovaMedica and Ferring Pharmaceuticals, a Swiss-based global biopharmaceutical company, have signed an agreement, that gives NovaMedica the rights for commercialization of a range of Ferring’s line of innovative gastroenterological prescription drug products for the treatment of inflammatory bowel disease (IBD) in the Russian market. The product line includes established and soon-to-launch treatments for inflammatory bowel diseases: ulcerative colitis, Crohn's disease and bleeding from esophageal varices. More information about the agreement ... 

Currently, this segment of NovaMedica’s portfolio is represented by the following products: 


Cortiment® – , a multi-matrix (MMX®) prolonged release budesonide, is indicated in adults for induction of remission in patients with mild to moderate active ulcerative colitis.

More information about the product...

Pentasa® is indicated for the induction and maintaining of remission in patients with mildly to moderately active ulcerative colitis and Crohn disease.

More information about the product...

Picoprep®  – is indicated to clean the bowel prior to X-ray examination or endoscopy, to clean the bowel prior to surgery when judged clinically necessary. PICOPREP® has approved dosing for children as of 9 year old and adults.

More information about the product...


All products passed Clinical Trials and registered in Russia.

PRODUCTS HAVE CONTRAINDICATIONS. PLEASE CONSULT A SPECIALIST BEFORE USE


According to partnership agreement with Omega Pharma, a European pharmaceutical company specialized in development and production of innovative OTC products, NovaMedica have acquired rights for promotion, distribution and sales of gastroenterological Benegast umbrella brand products in Russia. More information abot the agreement ... 

Currently, this segment of NovaMedica’s portfolio is represented by the following products: 

FOOD SUPPLEMENT. NOT A DRUG PRODUCT

Benegast Regulamine® helps to recover regular intestinal function.

•Regular intestinal function.

•No effect on hydro-electrolytic balance.

•100% natural fibers.

•Convenient dosage form: orange-flavored powder.

Benegast Redugas® helps to quickly reduce abdominal bloating and normalize intestinal microflora preventing repeated bloating.

•Double action: not only helps to relief discomfort but also normalizes intestinal microflora.

•Targeted action against bloating.

•Prevents repeated bloating.

•Convenient dosage form: mint-flavored chewing tablets.

Benegast Reduflux® helps to reduce heartburn.

•Protects stomach walls against acid.

•Convenient dosage form: mint-flavored chewing tablets.

Shareholders

Read more

Pipeline

Read more

Media Center

Read more